GSP Crop Science IPO Review

GSP Crop Science IPO has been reviewed by 12 analysts, and the overall consensus is May Apply — carrying a score of 64. Out of the 12 analysts who have covered this IPO, 6 recommend subscribing while 6 advise caution or avoidance — reflecting a mixed view from the analyst community.

The issue is priced in the band of ₹304-320 per share , with a minimum application size of 46 shares (minimum investment of approximately ₹14,720 at the upper band) . Subscription ran from 16 Mar 2026 to 18 Mar 2026. As of now, the grey market premium (GMP) for GSP Crop Science IPO is quoting at ₹2 (1%), which gives a preliminary sense of how the street is pricing the listing — though GMP is unofficial and can swing sharply before the listing date. Scroll down for the full analyst breakdown and analyst-wise verdicts.